NPY and neoplasm: NPY-loaded immune stimulating complexes (ISCN formulation) decreased growth and cytokine levels in MCF-7 tumor cells; cells were blocked in the G0/G1 phase, and many suffered apoptosis after treatment with the ISCN formulation [99].